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Critical roles of microRNA‑141‑3p
and CHD8 in hypoxia/reoxygenation‑induced
cardiomyocyte apoptosis
Bifeng Yao1†, Xiaoya Wan1†, Xinbin Zheng1, Ting Zhong1, Jia Hu1, Yu Zhou2, Anna Qin1, Yeshuo Ma1*
and Deling Yin1,3*

Abstract
Background: Cardiovascular diseases are currently the leading cause of death in humans. The high mortality of cardiac diseases is associated with myocardial ischemia and reperfusion (I/R). Recent studies have reported that microRNAs (miRNAs) play important roles in cell apoptosis. However, it is not known yet whether miR-141-3p contributes
to the regulation of cardiomyocyte apoptosis. It has been well established that in vitro hypoxia/reoxygenation (H/R)
model can follow in vivo myocardial I/R injury. This study aimed to investigate the effects of miR-141-3p and CHD8 on
cardiomyocyte apoptosis following H/R.
Results: We found that H/R remarkably reduces the expression of miR-141-3p but enhances CHD8 expression both
in mRNA and protein in H9c2 cardiomyocytes. We also found either overexpression of miR-141-3p by transfection
of miR-141-3p mimics or inhibition of CHD8 by transfection of small interfering RNA (siRNA) significantly decrease
cardiomyocyte apoptosis induced by H/R. Moreover, miR-141-3p interacts with CHD8. Furthermore, miR-141-3p and
CHD8 reduce the expression of p21.
Conclusion: MiR-141-3p and CHD8 play critical roles in cardiomyocyte apoptosis induced by H/R. These studies suggest that miR-141-3p and CHD8 mediated cardiomyocyte apoptosis may offer a novel therapeutic strategy against
myocardial I/R injury-induced cardiovascular diseases.
Keywords: MiR-141-3p, CHD8, Cardiomyocyte, Apoptosis, Hypoxia/reoxygenation, P21
Introduction
Cardiovascular diseases are currently the leading cause
of death in humans [1–5]. The high mortality of cardiac diseases is associated with myocardial ischemia
and reperfusion (I/R) [5]. Myocardial I/R is a pathological state featured by an initial limitation on the blood
supply to the heart, followed by blood reperfusion and
recovery of oxygen supply [6]. The recovery of blood
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supply and reoxygenation are always associated with
increased tissue damage and inflammatory responses,
which are known as reperfusion injury [1, 2]. Moreover, I/R injury may affect the treatment efficiency of
cardiac diseases, which could cause severe cell dysfunction, such as apoptosis and necrosis [6]. However, cardiomyocytes are terminally differentiated cells
that endogenous regenerative capacity of maintaining
cell function is insufficient during severe injury [7].
Therefore, inhibition of cardiomyocyte apoptosis may
have promised as a therapeutic strategy for I/R injury.
Recent studies have made some progress on mechanisms of myocardial I/R injury. However, clinical treatments are accompanied by low cure rate. Therefore,
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the molecular mechanisms of myocardial I/R injury
remain to be further explored.
MicroRNAs (miRNAs) are small, highly conserved,
and non-coding RNA, which containing approximately
22 nucleotides [8–10]. MiRNAs promote the degradation of mRNA or inhibit the translation of mRNA by
targeting the 3′ untranslated region of mRNA, thereby
regulating gene expression at post-transcriptional level
[10–12]. MiRNAs are dominant players in different
aspects of cardiovascular development [10], including cell apoptosis, cell proliferation, and differentiation [13–15]. Our previous studies by RNA sequencing
found that a long non-coding RNA is involved in
ischemia and reperfusion injury. Furthermore, we
found by database prediction that miR-141-3p is one
of the downstream of this long non-coding RNA (data
not shown). Previous studies reported that miR-141-3p
is associated with glioma cell growth [16], mesenchymal stem cell aging [17], and I/R injury in endothelial
cells [18]. However, the roles and mechanisms of miR141-3p in myocardial I/R injury or in hypoxia/reoxygenation (H/R) in vitro model remain to be elucidated.
Chromodomain helicase DNA-binding protein 8
(CHD8) is a member of ATP-dependent chromatin
remodeling protein in the CHD family [19]. CHD8
is related to the development of autism [20, 21], and
involved in embryonic development and apoptosis of
vascular smooth muscle cells [19, 22]. However, the
function of CHD8 in myocardial I/R injury and H/R is
not known yet.
P21, the well-known cyclin-dependent kinase inhibitor, is a 165 amino acids protein that confirmed to
play an important role in inhibition of cell cycle, suppression of tumor progress and cell apoptosis [23, 24].
Recent studies have reported p21 served as a proapoptosis regulator in cardiomyocytes [25]. But the
further mechanism still needs to be elucidated.
It has been well established that in vitro H/R model
can follow in vivo myocardial I/R injury [26, 27]. In
the current study, we performed the hypoxia/reoxygenation model, one that has been widely used to
investigate the mechanisms of myocardial I/R injury
[26, 27]. We found that the expression of miR-141-3p
attenuates cardiomyocyte apoptosis induced by H/R.
Additionally, downregulation of CHD8 inhibits cardiomyocyte apoptosis induced by H/R. Furthermore, we
found miR-141-3p and CHD8 reduce p21 expression.
Thus, our studies may provide a novel potential therapeutic target against myocardial I/R injury-induced
cardiovascular diseases.
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Materials and methods
Cell culture

H9c2 cardiomyocytes were obtained from the Cell Bank
of Shanghai Institute of Cell Biology, Chinese Academy
of Sciences. The cells were cultured with basic Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
fetal bovine serum. Cultures were incubated at 37 °C
and 5% CO2 in a fully humidified incubator.
The hypoxia/reoxygenation cell culture model

To establish the hypoxia/reoxygenation in vitro model,
H9c2 cardiomyocytes were cultured with low glucose
(1 mg/mL glucose) DMEM and incubated in an oxygenfree atmosphere (95% N
 2 and 5% C
 O2, 37 °C). After
8 h of culture, the cells were changed to a normal culture medium (4.5 mg/mL glucose) and normal atmosphere (95% air and 5% CO2, 37 °C) for another 48 h.
Cells in the control group were cultured under normal
conditions.
RNA isolation, reverse transcription and real‑time
quantitative RT‑PCR (qRT‑PCR) analysis

The qRT-PCR was performed as described previously
by our work [28]. Briefly, total RNA in H9c2 cells were
extracted using TRIzol reagent (Cwbio, Beijing, China).
Reverse transcription 1 μg RNA per sample using miDETECT A Track™ miRNA qRT-PCR Starter Kit (RiboBio
Co., Ltd, Guangzhou, China) to synthetic cDNA to detect
miR-141-3p. While using PrimeScript™ RT reagent Kit
(Perfect Real Time) (Takara, Japan) for other mRNAs.
PCR analysis was executed using iTaq™ universal SYBR®
Green Supermix (Bio-Rad, Hercules, CA). Expression
level of miR-141-3p was detected using U6 as internal
control, while expression levels of other mRNAs were
detected using GAPDH as internal control. The primer
sequences used are listed in Table 1.
Western blot analysis

Western blot analysis was performed as previous
described [29]. Briefly, total protein was extracted from
the cells using RIPA lysis buffer (Cwbio, Beijing, China),
which was added with Protease Inhibitor Cocktail (1%,
v/v) (Cwbio, Beijing, China). Then proteins were separated by 8% and 12% SDS-PAGE gels and electrotransfer onto Immobilon PVDF membranes (Merck KGaA,
Darmstadt, Germany). After blocking the membranes
with fat free milk, the membranes were incubated overnight at 4 °C with primary antibodies (Table 2). After
incubation with secondary antibodies (goat anti-rabbit
IgG, Proteintech, China), membranes were then imaged
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Table 1 Primers used for qRT-PCR
Gene

Forward primer sequence
(5′–3′)

Reverse primer sequence
(5′–3′)

NCBI accession ID

Length
of the amplicons

miR-141-3p

The primer sequences are proprietary information of the company. (RiboBio Co., Ltd, Guangzhou, China)

U6

ATTGGAACGATA
CAGAGAAGATT

GGAACGC TT
CACGAAT TTG

K00784

70 bp

CHD8

CCTCACGCAC
TGCT TCACCATC

CTCC TAGCCACC
ACCTCATCCTC

NM_001347661

133 bp

GAPDH

GGTGGACCTCA
TGGCCTACA

CTCTCTTGCTCTC
AGTATCC TTGCT

NM_017008.4

84 bp

Table 2 Antibodies used for Western blotting
Name

Description

Manufacturer

Anti-β-actin

Rabbit monoclonal, 43 kDa

Proteintech (20,536–1-AP)

Anti-Caspase-3

Rabbit monoclonal, 34 kDa

CST (#9662S)

Anti-Cleaved caspase-3

Rabbit monoclonal, 16 kDa

CST (#9664S)

Anti-CHD8

Rabbit monoclonal, 290 kDa

CST (#77,694)

Anti-p21

Rabbit monoclonal, 21 kDa

Abcam (109,199)

by an enhanced chemiluminescent detection kit (Cwbio,
Beijing, China).
Cell apoptosis detection by flow cytometric analysis

Flow cytometric analysis was performed as previous
described by us [30]. Apoptotic cells were determined by
flow cytometer (Becton, Dickinson and Company, CA,
USA) and the percentage of apoptotic cells was determined by FITC Annexin V Apoptosis Detection Kit I
(BD Biosciences, Franklin Lakes, NJ, USA). Cells were
gathered according to the manufacturer’s instructions
and cells were rinsed twice with cold PBS and then resuspended in binding buffer at a concentration of 1 × 106
cells/ mL. 100 µl of the solution (1 × 105 cells) was transferred to per culture tube, 5 µl of FITC Annexin V and
5 µl PI were added subsequently. Then, the cells were
gently vortexed and incubated for 15 min at RT in the
dark. Finally, 400 µl of binding buffer were putted into
each tube and analyzed by flow cytometry within 1 h.
Transfection of overexpression mimics or siRNA

Mimics and small interfering RNA transfection (siRNA)
were performed as described previously by us [31].
Briefly, H9c2 cells were cultured in 6-wells plates. To
overexpression of miR-141-3p, when H9c2 cells were
visualized at 40% density, transient transfected with
miR-141-3p mimics or miR-141-3p negative control
(miR-141-3p NC) (GenePharma, Shanghai, China) using
Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instruction. After 48 h

culture, H9c2 cells were harvested for H/R treatment or
further study. The miR-141-3p mimics and miR-141-3p
NC sequences used are as follows:
miR-141-3p mimics: 5′-UAACACUGUCUGGUAAAG
AUGG-3′;
miR-141-3p negative control: 5′-ACGUGACACGUU
CGGAGAATT-3′;
Similarly, to knockdown the expression of CHD8,
siRNA oligonucleotides against CHD8 and negative control siRNA (NC-Si) were designed and synthesized by
the RiboBio Co., Ltd. (Guangzhou, China). H9c2 cells
were transient transfected with a mixture of siRNA using
Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA)
after observed at 40% density. After 48 h culture, the
knockdown efficiency was determined by Western blot
analysis and for further study. The siRNA sequences used
are as follows:
CHD8-siRNA: 5′-CGATGTTACTGGTCCAATA-3′;
Negative control siRNA: 5′-TTCTCCGAACGTGTC
ACGT-3′.
RNA immunoprecipitation (RIP)

RIP was carried out using CHD8 antibody and the IgG
antibody, which was served as negative control [32].
Briefly, the cells were harvested by RIPA lysis buffer
containing Protease Inhibitor Cocktail and RiboLock
RNase inhibitor (1%, v/v) (Thermo Fisher Scientific,
Waltham, MA, USA) according to the manufacture’s
instruction. Obtained samples were incubated for 1 h
at 4 °C. Then, Protein A/G PLUS-Agarose was added
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into the samples and rotated overnight at 4 °C. Beads
were washed for 4 times using lysis buffer. Finally,
divided the samples into two equal parts respectively.
One for Western blot analysis to determined expression level of CHD8, and the other for qRT-PCR analysis to detect expression level of miR-141-3p.
Statistical analysis

Graphpad Prism 5.01 was used to analyze data in this
study. The results were presented as mean ± SD. The
data were analyzed using one-way analysis of variance
and Student’s t-test. A value of P < 0.05 was considered
to be statistically significant.

Results
MiR‑141‑3p is downregulated by hypoxia/reoxygenation
(H/R) in H9c2 cardiomyocytes

To investigate whether miR-141-3p plays a role in
H/R-induced injury in cardiomyocytes. We first evaluated the morphological alterations of H9c2 cardiomyocytes following H/R and observed that H/R promoted
cell damage and reduced the number of H9c2 cardiomyocytes (Fig. 1a). We then determined the expression level of miR-141-3p following H/R treatment by
real-time quantitative RT-PCR (qRT-PCR). As shown
in Fig. 1b, the expression level of miR-141-3p was dramatically decreased in H9c2 cardiomyocytes following
H/R treatment, indicating that miR-141-3p might be
involved in cardiomyocyte H/R injury.
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Overexpression of miR‑141‑3p dramatically decreases
H/R‑induced H9c2 cardiomyocyte apoptosis

To determine whether miR-141-3p contributed to H/R
induced cardiomyocyte apoptosis, we examined the
alterations of apoptotic marker cleaved caspase-3 (Clcaspase-3) protein and also performed flow cytometric
analysis in H9c2 cardiomyocytes after transfection with
miR-141-3p mimics. We found that overexpression of
miR-141-3p significantly inhibited H/R-induced Cl-caspase-3 (Fig. 2a) and apoptosis in H9c2 cardiomyocytes
(Fig. 2b). Taken together, these results reveal that miR141-3p plays a critical role in cardiomyocyte apoptosis
induced by H/R.
H/R induces the expression of CHD8 in H9c2
cardiomyocytes

We then evaluate whether the expression of CHD8 was
altered following H/R. Our results showed that H/R significantly increased CHD8 expression in both protein
and mRNA levels in H9c2 cardiomyocytes (Fig. 3a, b),
indicating that CHD8 may participate in cardiomyocyte
apoptosis induced by H/R.
Downregulation of CHD8 inhibits H9c2 cardiomyocyte
apoptosis induced by H/R

To assess the role of CHD8 in H/R induced apoptosis,
H9c2 cardiomyocyte were transfected with small interfering RNA (siRNA). As shown in Fig. 4a, inhibition of
CHD8 significantly decreased the expression level of Clcaspase-3 induced by H/R. Moreover, we performed flow
cytometry analysis and found that inhibition of CHD8
dramatically diminished the number of cardiomyocyte

Fig. 1 MiR-141-3p is downregulated by hypoxia/reoxygenation (H/R) in H9c2 cardiomyocytes. H9c2 cardiomyocytes were subjected to hypoxia
treatment for 8 h with low glucose (1 mg/mL glucose) DMEM and oxygen-free atmosphere (95% N
 2 and 5% C
 O2, 37 °C), then reoxygenated for
48 h with normal culture medium (4.5 mg/mL glucose) and normal atmosphere (95% air and 5% C
 O2, 37 °C). a The alteration of morphology was
observed by microscope. b The expression of miR-141-3p was determined by qRT-PCR. N = 3 per group. *P < 0.05, compared with control group
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Fig. 2 Overexpression of miR-141-3p decreases H/R induced apoptosis in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected
with miR-141-3p mimics or miR-141-3p NC for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. Transfected H9c2
cardiomyocytes were subjected to hypoxia treatment for 8 h, then reoxygenated for 48 h as in Fig. 1. a The cleaved caspase-3 (Cl-caspase-3) and
caspase-3 were measured by Western blot analysis. b Apoptotic cells were determined by flow cytometric analysis. N = 3 per group. NC negative
control. *P < 0.05, **P < 0.01, compared with indicated groups
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transfection with miR-141-3p mimics or CHD8-Si following H/R treatment (Fig. 6c, d). Therefore, these results
suggest that p21 contributes to miR-141-3p and CHD8
mediated signaling in H/R.

Fig. 3 CHD8 is upregulated by H/R in H9c2 cardiomyocytes. H9c2
cardiomyocytes were subjected to hypoxia treatment for 8 h,
then reoxygenated for 48 h as in Fig. 1. a The expression of CHD8,
Cl-caspase-3, and caspase-3 was examined by Western blot. b CHD8
miRNA expression was determined by qRT-PCR. N = 3 per group.
*P < 0.05, **P < 0.01, compared with control group

apoptosis induced by H/R (Fig. 4b). These results demonstrated that knockdown of CHD8 could ameliorate H/R
induced cardiomyocyte apoptosis.
MiR‑141‑3p interacts with CHD8 in H9c2 cardiomyocytes

We then examined whether there is interaction between
miR-141-3p and CHD8. We showed that overexpression of miR-141-3p reduced the expression of CHD8 in
both protein and mRNA levels (Fig. 5a, b). Interestingly,
inhibition of CHD8 increased the expression level of
miR-141-3p (Fig. 5c). Therefore, we examined the relationship between them by RIP analysis. Collected H9c2
cardiomyocytes were extracted by RIPA lysis buffer. As
shown in Fig. 5d, e, qRT-PCR and Western blot analysis showed the relationship between miR-141-3p and
CHD8. In addition, we didn’t find complementary base
pairs of miR-141-3p and CHD8 mRNA by searching for
TargetScan (data not shown). Collectively, these findings
suggested that there is an indirect interaction between
miR-141-3p and CHD8 in H9c2 cardiomyocytes.
MiR‑141‑3p and CHD8 can reduce the expression of p21
in H9c2 cardiomyocytes

Previous study has shown that p21 could act as an apoptosis promoting regulator [25]. We therefore investigated
that whether miR-141-3p or CHD8 plays a role in alteration of p21 expression. Notably, we found that either
overexpression of miR-141-3p or inhibition of CHD8
significantly decreased the expression of p21 (Fig. 6a, b).
We further determined whether miR-141-3p or CHD8
had effect on p21 expression following H/R. Our results
showed that the expression of p21 was decreased after

Discussion
To the best of our knowledge, the results of this study
reveal for the first time that miR-141-3p is downregulated
and exerts as a protective regulator against H/R induced
cardiomyocyte apoptosis. Subsequently, CHD8 is verified
to act as a pro-apoptotic molecular in H/R induced cardiomyocyte apoptosis. Meanwhile, miR-141-3p and CHD8
regulate the expression of p21. These studies reveal that
miR-141-3p, a potential target of myocardial I/R injury,
may provide a novel therapeutic strategy on cardiac diseases, which based on interacting with CHD8.
Myocardial I/R injury has become a prominent problem that influences therapeutical effect of reperfusion
therapy on ischemic myocardium [33]. Further, reperfusion accelerates the process of apoptosis induced by
ischemia itself [34]. Due to the apoptosis of cardiomyocytes in the ischemic site occurs immediately, it causes
enrichment of reactive oxygen species with reperfusion
progressing, which eventually aggravates the degree of
apoptosis [35, 36]. Thus, it’s well established that ameliorating apoptosis plays a pivotal role against I/R injury.
Increasing number of miRNAs, such as miR-25 and
miR-762 modulate the expression of key molecular associated with apoptosis in myocardial I/R injury [37, 38].
Previous studies have shown that miR-141-3p alters the
expression of p53 as a reason of promoting glioblastoma
progression and temozolomide resistance [16]. MiR141-3p also has impact on mesenchymal stem cell senescence by directly targeting ZMPSTE24 [17]. MiR-141
decreases myocardial I/R injury in endothelium by regulating expression of ICAM-1 [18]. In our study, the results
showed that the expression of miR-141-3p is significantly
downregulated and overexpression of miR-141-3p alleviates the cardiomyocyte apoptosis induced by H/R.
CHD8 is a protective molecular in apoptosis. It
decreased p53-mediated apoptosis during early embryogenesis [22]. In addition, it was also confirmed to act as
an inhibitor of apoptosis in A10 vascular smooth muscle
cells [19]. Surprisingly, the results of our study showed
that the expression of CHD8 is increased and it promotes
H9c2 cardiomyocyte apoptosis following H/R. Our study
unveiled for the first time that CHD8 plays an important
role in cardiomyocyte apoptosis, which also indicates
its significant function in cardiac diseases. Our results
from Western blot, qPCR, and RIP analysis all showed
that miR-141-3p and CHD8 have effects on each other.
However, we could not find complementary sequences
between them by bioinformatic analysis. Our data
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Fig. 4 Knockdown of CHD8 inhibits apoptosis induced by H/R in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected with CHD8-siRNA
(CHD8-Si) or negative control-siRNA (NC-Si) for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. Transfected H9c2
cardiomyocytes were subjected to hypoxia treatment for 8 h, then reoxygenated for 48 h as in Fig. 1. a The expression of Cl-caspase-3 and
caspase-3 was determined by Western blot. b Apoptotic cells were determined by flow cytometric analysis. N = 3 per group. *P < 0.05, **P < 0.01,
compared with indicated groups

Yao et al. Cell Biosci

(2020) 10:20

Page 8 of 10

Fig. 5 MiR-141-3p interacts with CHD8 in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected with miR-141-3p mimics or miR-141-3p
NC for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. CHD8 expression was examined by Western blot (a) and qRT-PCR
(b). c H9c2 cardiomyocytes were transfected with CHD8-siRNA (CHD8-Si) or negative control-siRNA (NC-Si) for 6 h in low glucose DMEM, then
cultured for another 48 h in basic DMEM. The expression of miR-141-3p was examined by qRT-PCR. The relationship between miR-141-3p and CHD8
was determined by RIP analysis (d, e). Collected H9c2 cardiomyocytes were extracted by RIPA lysis buffer. Obtained samples were pre-incubated
with protein A/G PLUS-agarose. The samples were then divided into two parts equally and incubated with IgG and CHD8 overnight separately.
Washed samples and then divided each sample into two parts, one for Western blot analysis and the other for qPCR analysis. d The expression
level of miR-141-3p was measured by qRT-PCR. e The protein expression level of CHD8 was examined by Western blot analysis. N = 3 per group. NC
negative control. *P < 0.05, **P < 0.01, compared with indicated groups

suggest that other protein(s) may mediate between them,
which will be investigated in our future studies.
Previous studies have reported that p21 served as a
regulator of anti-apoptosis [39, 40], while other studies verified its pro-apoptotic effect [25]. It inhibits
the activation of cell cycle which is necessary to initiate apoptosis. Otherwise, under certain conditions,
p21 promotes cell apoptosis in either p53-dependent

or p53-independent mechanisms [41]. In our current study, the results reveal for the first time that
the expression of p21 is regulated by miR-141-3p and
CHD8. But it still remains further studies that whether
the effects of miR-141-3p and CHD8 in H/R induced
apoptosis is through p21. We recognize that the limitation of this study was that only a single cell line
and more cell lines will be determined in our future
studies.
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Fig. 6 MiR-141-3p and CHD8 reduce the expression level of p21 in H9c2 cardiomyocytes. H9c2 cardiomyocytes were transfected with miR-141-3p
mimics or CHD8-Si for 6 h in low glucose DMEM, then cultured for another 48 h in basic DMEM. a P21 expression was examined by Western
blot. b The expression of p21 and CHD8 was determined by Western blot. After transfected with miR-141-3p mimics or CHD8-Si as a, b, H9c2
cardiomyocytes were subjected to hypoxia treatment for 8 h, then reoxygenated for 48 h as in Fig. 1. c, d P21 expression was examined by Western
blot. N = 3 per group. *P < 0.05, **P < 0.01, compared with indicated groups

Conclusion
In summary, this is the first study to provide evidence
illustrating that the expression of miR-141-3p attenuates cardiomyocyte apoptosis induced by H/R by interacting with CHD8. Our findings indicated that the
mechanism underlying miR-141-3p and CHD8 interaction in H/R induced cardiomyocyte apoptosis may provide a novel therapeutic strategy against myocardial I/R
injury-induced cardiovascular diseases.
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